Current and Emerging Approaches to Evaluating Influenza Vaccine Performance
NEJM December 10, 2025
Kathleen M. Neuzil
Abstract
Randomized, placebo-controlled trials are widely accepted as the scientific reference standard to determine a causal association between an intervention and an outcome. They are pivotal for product licensure. Although such trials establish safety and efficacy with the assumption that bias has been eliminated, limitations remain. For vaccines, establishing the duration of...
Related Articles:
2025-12-11T19:58:48-05:00